{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:16:39Z","timestamp":1791332199182,"version":"4.3.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopha.2018.06.103","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T01:04:38Z","timestamp":1529715878000},"page":"1291-1298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt"],"prefix":"10.1016","volume":"105","author":[{"given":"Yingli","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.103_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010124","article-title":"Extracorporeal shock wave therapy alters the expression of fibrosis-related molecules in fibroblast derived from human hypertrophic scar","volume":"19","author":"Cui","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.06.103_bib0010","first-page":"27","article-title":"Recent advances in hypertrophic scar","volume":"33","author":"Zhang","year":"2018","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2018.06.103_bib0015","first-page":"1","article-title":"Identification of the potential targets for keloid and hypertrophic scar prevention","author":"Zhang","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.biopha.2018.06.103_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112274","article-title":"The four-herb Chinese medicine ANBP enhances wound healing and inhibits scar formation via bidirectional regulation of transformation growth factor pathway","volume":"9","author":"Hou","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.06.103_bib0025","first-page":"164","article-title":"Clnical observation, of the effects of lattice ultra pulse carbon dioxide laser combined with traditional Chinese medicine on the treatment of hyperplastic scar","volume":"31","author":"Jin","year":"2015","journal-title":"Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chin. J. Burns."},{"key":"10.1016\/j.biopha.2018.06.103_bib0030","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.3390\/ijms14035576","article-title":"Naringin enhances CaMKII activity and improves long-term memory in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2018.06.103_bib0035","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.bmcl.2017.04.076","article-title":"Anti-atherosclerotic activities of flavonoids from the flowers of Helichrysum arenarium L. MOENCH through the pathway of anti-inflammation","volume":"27","author":"Mao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.06.103_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.44","article-title":"IL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways","volume":"7","author":"Shi","year":"2016","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2018.06.103_bib0045","article-title":"MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts","volume":"9","author":"Zhu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2018.06.103_bib0050","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s13277-015-3990-1","article-title":"Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades","volume":"37","author":"Guo","year":"2016","journal-title":"Tumour Biology"},{"key":"10.1016\/j.biopha.2018.06.103_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/adt.2006.029","article-title":"A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors","volume":"5","author":"Baki","year":"2007","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.biopha.2018.06.103_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2013.05.006","article-title":"Naringin inhibits growth potential of human triple-negative breast cancer cells by targeting beta-catenin signaling pathway","volume":"220","author":"Li","year":"2013","journal-title":"Toxicol. Letters"},{"key":"10.1016\/j.biopha.2018.06.103_bib0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.fct.2012.07.033","article-title":"Naringin induces death receptor and mitochondria-mediated apoptosis in human cervical cancer (SiHa) cells","volume":"51","author":"Ramesh","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2018.06.103_bib0070","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1080\/13880209.2016.1216131","article-title":"Therapeutic potential of naringin: an overview","volume":"54","author":"Chen","year":"2016","journal-title":"Pharmaceutical Biol."},{"key":"10.1016\/j.biopha.2018.06.103_bib0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.intimp.2014.06.029","article-title":"Naringin suppress chondrosarcoma migration through inhibition vascular adhesion molecule-1 expression by modulating miR-126","volume":"22","author":"Tan","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2018.06.103_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1524-475X.2010.00643.x","article-title":"Akt-mediated mechanotransduction in murine fibroblasts during hypertrophic scar formation","volume":"19","author":"Paterno","year":"2011","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.biopha.2018.06.103_bib0085","article-title":"Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K\/AKT and STAT3 signaling pathways in scar-forming fibroblasts","volume":"9","author":"Shi","year":"2014","journal-title":"PloS One."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218321991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218321991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:41:12Z","timestamp":1731447672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218321991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":17,"alternative-id":["S0753332218321991"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.103","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}